About Fludarabine Phosphate
            
            Class: | Antineoplastic agent, Purine analog  
Use: | Treatment of B-cell chronic lymphocytic leukemia (CLL) in patients who have not responded to or have progressed during treatment with at least one standard alkylating agent-containing regimen.  
Adult dose: | The recommended adult dose is 40 mg/m² orally once daily for 5 consecutive days every 28 days.  
Pediatric dose: | Safety and efficacy in pediatric patients have not been established; therefore, dosing information is not available.  
Sid
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Purine analog
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of B-cell chronic lymphocytic leukemia (CLL) in patients who have not responded to or have progressed during treatment with at least one standard alkylating agent-containing regimen.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light and moisture.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bayer AG, GERMANY
                    
                    
                    Package Size
                    20's
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4117.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        The recommended adult dose is 40 mg/m² orally once daily for 5 consecutive days every 28 days.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy in pediatric patients have not been established; therefore, dosing information is not available.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include myelosuppression, fever, infection, nausea, vomiting, diarrhea, fatigue, cough, and rash.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with severe renal impairment (creatinine clearance < 30 mL/min), and in those with hypersensitivity to fludarabine phosphate or any component of the formulation.
         
        
        
            
                Important Warnings
            
            Fludarabine phosphate can cause severe bone marrow suppression, increased risk of opportunistic infections, autoimmune hemolytic anemia, and neurotoxicity. It should be used with caution in patients with renal impairment and requires regular monitoring of blood counts.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.